2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Drivers Are Shaping the Growth and Development of theCardiac Amyloidosis Market?

The increasing geriatric population is expected to propel the growth of the cardiac amyloidosis market going forward. The geriatric population, typically aged 65 and above, is growing due to increased life expectancy, better healthcare, and lower birth rates. Aging is a major risk factor for cardiac amyloidosis, which involves the buildup of amyloid proteins in the heart, potentially leading to heart failure. According to the Population Reference Bureau, in January 2024, the U.S. population aged 65 and older is expected to grow from 58 million in 2022 to 82 million by 2050, marking a 47% increase. Therefore, the aging population is expected to drive the growth of the cardiac amyloidosis market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21128&type=smp

#What is the Growth Potential of the Cardiac Amyloidosis Market, and How Will It Perform by 2034?

The cardiac amyloidosis market has seen steady growth, with projections showing an increase from $5.26 billion in 2024 to $5.75 billion in 2025 at a CAGR of 9.2%. Contributing factors to past growth include the rising prevalence of amyloidosis-related conditions, increasing cases of transthyretin amyloidosis, greater awareness, the impact of genetic mutations, and an aging population.

The cardiac amyloidosis market is projected to expand significantly, reaching $8.10 billion by 2029 at a CAGR of 9.0%. Growth in this sector is attributed to improved diagnosis rates, government support and initiatives, an increase in genetic mutation-related cases, and the availability of patient assistance programs. Notable trends expected in this period include the development of innovative therapies such as vulrisiran, growing research in gene therapy, advancements in precision medicine, improvements in diagnostic technologies, and the introduction of novel therapeutic options.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21128

Which Cutting-Edge Market Trends Are Expected to Drive theCardiac Amyloidosis Market’s Growth?

In the cardiac amyloidosis market, companies are utilizing artificial intelligence (AI) to enhance early diagnosis and clinical outcomes. For instance, in November 2024, Ultromics Ltd., a UK-based health technology company, received FDA clearance for EchoGo Amyloidosis, an AI-powered tool for detecting cardiac amyloidosis. This diagnostic tool analyzes echocardiograms to identify the disease early, addressing the need for quicker diagnosis and intervention.

What Are the Leading Market Players Impacting theCardiac Amyloidosis Market’s Growth Trend?

Major companies operating in the cardiac amyloidosis market are Pfizer Inc., Sanofi S.A., AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Novo Nordisk A/S, Alexion Pharmaceuticals Inc., Dr. Reddy’s Laboratories, Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Akcea Therapeutics Inc., BridgeBio Pharma Inc., Prothena Corp, Intellia Therapeutics Inc., Amylyx Pharmaceuticals, Neurimmune AG, SOM Biotech, Oncopeptides, Attralus Inc., Eidos Therapeutics.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/cardiac-amyloidosis-global-market-report

How Are the Key Segments of the Cardiac Amyloidosis Market Driving Opportunities and Innovations?

The cardiac amyloidosis market covered in this report is segmented –

1) By Product Type: Light Chain Amyloidosis, Transthyretin Amyloidosis

2) By Treatment: Chemotherapy, Surgery, Supportive Care, Stem Cell Transplant, Targeted Therapy

3) By End-User: Hospitals, Ambulatory Surgical Centres, Clinics

Subsegments:

1) By Light Chain Amyloidosis: Immunoglobulin Light Chain (AL) Amyloidosis, Primary Light Chain Amyloidosis, Secondary Light Chain Amyloidosis

2) By Transthyretin Amyloidosis: Hereditary Transthyretin Amyloidosis (ATTRm), Wild-type Transthyretin Amyloidosis (ATTRwt)

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=21128&type=smp

What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of theCardiac Amyloidosis Market?# Market Expansion?

North America was the largest region in the cardiac amyloidosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac amyloidosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Cardiac Amyloidosis Market 2025, By The Business Research Company:

Aminoglycosides Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/aminoglycosides-global-market-report

Glycomics or Glycobiology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/glycomics-or-glycobiology-global-market-report

Smart Insulin Pens Global Market Report 2025

https://thebusinessresearchcompany.com/report/smart-insulin-pens-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: